Danaher Corporation Visit

Cambridge Innovation Capital is a leading venture investor in the Cambridge ecosystem. Their proprietary agreement with the University of Cambridge and their deep network of entrepreneurs, research institutes and accelerators, gives them a deep insight into the next generator of globally impactful start-ups.

They manage over £500 million and have invested in 30+ companies. They invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.

Website

Twitter

Connect with Michael Anstey

University of Cambridge talent is renowned for delivering life-changing innovations with global impact. Cambridge Enterprise Ventures invest University of Cambridge capital into high impact, high growth Cambridge spin-outs and start-ups. They are here to enable the entrepreneurial academics, students, graduates, and recent alumni from Cambridge by providing early-stage equity investment and support.

Leveraging the many benefits of the Cambridge ecosystem, they accelerate the journey by making investments across the breadth of the University: helping build ventures, introducing NED talent, developing business models and providing access to their co-investor community.

Find out more

Linked In

Connect with Christine Martin

Amadeus Capital Partners is a global technology investor. Since 1997, the firm has backed more than 190 companies and raised over $1 billion for investment.

Amadeus Capital Partners offers over 20 years’ experience in technology investment. They invest across the world, from their bases in London, Cambridge and Oxford in the UK, Lausanne and San Francisco. They focus on early stage in the UK, plus primary and secondary growth capital in Europe and Latin America.

Website

Twitter

Connect with Pierre Socha

IQ Capital’s general partners, Kerry Baldwin, Max Bautin, Simon Hirtzel and Ed Stacey, have worked together for more than 20 years, investing in innovative Deep Tech companies that are distinctly identifiable within the market for possessing defensible IP, breakthrough technologies and global ambitions.

From Seed stage, IQ Capital helps founders tackle the challenges faced in building and scaling a successful company, supported by the diverse perspectives of a team built on thorough knowledge of deep science and technology, as well as marketing, finding product-market-fit, sales, talent, corporate finance and M&A. They have achieved over 20 exits to date, including trade sales to Oracle, Google, Apple, Facebook, Siemens and several IPOs.

Website

Twitter

Connect with Max Bautin

Concr enables the personalisation of cancer treatment by providing advanced analytics tools for precise and accurate response predictions, in pre-clinical models and in patients.

Founded by a biomedical engineer, a computational physicist and a medical oncologist, Concr uses established computational frameworks from astrophysics to enable learning between disparate and messy oncology data to accurately model cancer biology.

Point of Contact: Amanda Wooding

Academic founders: Matthew Foster, Irina Babina, Matthew Griffiths

Website

Case Study

Sphere Fluidics is a life sciences company specialising in single cell analysis and isolation. They use picodroplet microfluidic technology to provide high-throughput platforms and consumables for biopharmaceutical discovery, cell therapy engineering, and synthetic biology.

Point of Contact: Amanda Wooding

Academic founders: Chris Abell, Wilhelm Huck

Website

Zetta Genomics
Zetta Genomics provides advanced genomic data management solutions to enable continuous re-interpretation of genomic data at speed and scale, enhancing precision medicine and improving health outcomes for millions of patients around the world.

Point of Contact: Amanda Wooding

Academic founders: Ignacio Medina, William Spooner, Jim Cook

Website